Close Menu
Home » NRGene, RCK Partner to Develop Medical Cannabis DNA Biomarkers

NRGene, RCK Partner to Develop Medical Cannabis DNA Biomarkers

Sep 04, 2018
|
staff reporter

NEW YORK (GenomeWeb) — NRGene said today that it has partnered with Israeli cannabis production company RCK to develop DNA-based biomarkers for medical cannabis breeding and strain identification.

Under the terms of the deal, the partners will use NRGene's computational tools to develop the biomarkers for commercial use. Additional terms were not disclosed.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Scan

That Rude Reviewer

ScienceInsider reports that rude and unprofessional paper reviewers are common and can have harmful effects.

New FDA Commish Confirmed

The US Senate has confirmed Stephen Hahn as the next commissioner of the Food and Drug Administration, according to the New York Times.

DNA Screening for Apple Employees

CNBC reports Apple is partnering with Color Genomics to offer its employees free DNA screening for disease.

Science Studies Describe Role for Microbiome-Derived Immunity, Platform to Develop Flavivirus Vaccines

In Science this week: researchers use CRISPR tool to find gut microbiome molecules involved in immunity, and more.

What's Popular?

In Informatics

  1. Celmatix Sues 23andMe for $100M Alleging Breach of Contract

  2. DNA Storage Architecture Could Be Used to Store Health Records, Develop Self-Replicating Machines

  3. Biotia Raises $2.4M in Seed Financing

  4. Colorado Center for Personalized Medicine Biobank Begins Returning Participant PGx Results

    Premium

  5. Oncology Pharma to Acquire Stake in Diagnomics

Sponsorships

Privacy Policy.  Terms & Conditions.  Copyright © 2019 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.